Page last updated: 2024-10-22

amobarbital and Fibrosarcoma

amobarbital has been researched along with Fibrosarcoma in 1 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schulze-Osthoff, K1
Bakker, AC1
Vanhaesebroeck, B1
Beyaert, R1
Jacob, WA1
Fiers, W1

Other Studies

1 other study available for amobarbital and Fibrosarcoma

ArticleYear
Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation.
    The Journal of biological chemistry, 1992, Mar-15, Volume: 267, Issue:8

    Topics: Amobarbital; Animals; Antimycin A; Cell Line; Cell Survival; Electron Transport; Electron Transport

1992